[MNGIE (mitochondrial neurogastrointestinal encephalomyopathy)]
- PMID: 11596354
[MNGIE (mitochondrial neurogastrointestinal encephalomyopathy)]
Similar articles
-
Four novel thymidine phosphorylase gene mutations in mitochondrial neurogastrointestinal encephalomyopathy syndrome (MNGIE) patients.Eur J Hum Genet. 2003 Jan;11(1):102-4. doi: 10.1038/sj.ejhg.5200908. Eur J Hum Genet. 2003. PMID: 12529715
-
Mitochondrial neurogastrointestinal encephalomyopathy mimicking anorexia nervosa.Am J Psychiatry. 2009 Apr;166(4):494-5. doi: 10.1176/appi.ajp.2008.08101525. Am J Psychiatry. 2009. PMID: 19339372 No abstract available.
-
A novel TYMP mutation in a French Canadian patient with mitochondrial neurogastrointestinal encephalomyopathy.Clin Neurol Neurosurg. 2009 Oct;111(8):691-4. doi: 10.1016/j.clineuro.2009.05.005. Epub 2009 Jun 12. Clin Neurol Neurosurg. 2009. PMID: 19523753
-
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches.Biosci Rep. 2007 Jun;27(1-3):151-63. doi: 10.1007/s10540-007-9043-2. Biosci Rep. 2007. PMID: 17549623 Review.
-
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes.Neurologist. 2004 Jan;10(1):8-17. doi: 10.1097/01.nrl.0000106919.06469.04. Neurologist. 2004. PMID: 14720311 Review.
Cited by
-
Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies.Pharmaceutics. 2020 Nov 11;12(11):1083. doi: 10.3390/pharmaceutics12111083. Pharmaceutics. 2020. PMID: 33187380 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical